Comments to FDA: Laxative Drug Products

Share page:
Docket Number:
1978N-036L

The Food and Drug Administration announced a reopening of the administrative record for the rulemaking for OTC laxative drug products. CHPA sees this as an appropriate time to get clarification on an allowable statement of identity for OTC laxative drug products that contain fiber and on an indication under the monograph.

Issues: